These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35781322)

  • 1. Treatment of overactive bladder in men: Is it really different?
    Shapiro KK; Brucker BM
    Neurourol Urodyn; 2022 Nov; 41(8):1975-1982. PubMed ID: 35781322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemic investigation of benign prostatic obstruction with coexisting overactive bladder in Shanghai Pudong New Area and its impact on the health-related quality of life.
    Yi QT; Gong M; Chen CH; Hu W; Zhu RJ
    BMC Urol; 2019 Sep; 19(1):82. PubMed ID: 31481034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial combined treatment with anticholinergics and α-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study.
    Lee SH; Chung BH; Kim SJ; Kim JH; Kim JC; Lee JY
    Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):320-5. PubMed ID: 21788967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of anticholinergics in patients with benign prostatic hyperplasia.
    Athanasopoulos A; Mitropoulos D; Giannitsas K; Perimenis P
    Expert Opin Drug Saf; 2008 Jul; 7(4):473-9. PubMed ID: 18613810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undertreatment of overactive bladder among men with lower urinary tract symptoms in the United States: A retrospective observational study.
    Burnett AL; Walker DR; Feng Q; Johnston KM; Lozano-Ortega G; Nimke D; Hairston JC
    Neurourol Urodyn; 2020 Jun; 39(5):1378-1386. PubMed ID: 32383533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Patterns and Patient Reported Outcomes in Benign Prostatic Hyperplasia Patients with Overactive Bladder Symptoms.
    Park YH; Kim TH; Lee SW; Chung BH; Cho JS; Lee JY
    Low Urin Tract Symptoms; 2017 May; 9(2):75-81. PubMed ID: 28394492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Mirabegron in Men with Overactive Bladder Symptoms and Benign Prostatic Hyperplasia.
    Mullen GR; Kaplan SA
    Curr Urol Rep; 2021 Jan; 22(1):5. PubMed ID: 33411109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does anticholinergic medication have a role in treating men with overactive bladder and benign prostatic hyperplasia?
    Lee KS; Lee HW; Han DH
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):491-501. PubMed ID: 18172610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of systemic atherosclerosis on overactive bladder symptoms in men with benign prostatic hyperplasia.
    Lee D; Koo KC; Yoo JW; Lee KS
    Low Urin Tract Symptoms; 2022 Jan; 14(1):35-40. PubMed ID: 34323012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms?
    Cornu JN; Grise P
    Curr Opin Urol; 2016 Jan; 26(1):17-21. PubMed ID: 26574877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between lower urinary tract symptoms and urinary ATP in patients with benign prostatic hyperplasia or overactive bladder.
    Sugaya K; Nishijima S; Kadekawa K; Miyazato M; Mukouyama H
    Biomed Res; 2009 Oct; 30(5):287-94. PubMed ID: 19887725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of use of urinary antimuscarinics and alpha blockers for benign prostatic hyperplasia in older adults at risk of falls: a clinical review.
    İlhan B; Erdoğan T; Topinková E; Bahat G;
    Eur Geriatr Med; 2023 Aug; 14(4):733-746. PubMed ID: 37245173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The urologist's view of male overactive bladder: discrepancy between reality and belief in practical setting.
    Lee SH; Kim DK; Kim JC; Lee KS; Lee JG; Park CH; Hong SJ; Kim CS; Park JK; Chung BH
    Yonsei Med J; 2010 May; 51(3):432-7. PubMed ID: 20376898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction.
    Pang R; Zhou XY; Wang X; Wang B; Yin XL; Bo H; Jung JH
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012336. PubMed ID: 33567116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia.
    Höfner K; Burkart M; Jacob G; Jonas U
    World J Urol; 2010 Jun; 28(3):353-7. PubMed ID: 19997921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder.
    Chapple CR; Roehrborn CG
    Eur Urol; 2006 Apr; 49(4):651-8. PubMed ID: 16530611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of medical management of overactive bladder (OAB) and benign prostatic hyperplasia (BPH) in the United States.
    Anger JT; Goldman HB; Luo X; Carlsson MO; Chapman D; Zou KH; Russell D; Ntanios F; Esinduy CB; Clemens JQ
    Neurourol Urodyn; 2018 Jan; 37(1):213-222. PubMed ID: 28455944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vibegron, a novel β
    Maruyama I; Yamamoto S; Tsuchioka K; Yamazaki T
    Eur J Pharmacol; 2020 Jul; 878():173096. PubMed ID: 32259514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.